| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Are glycated serum proteins ready for prime time?
|
Cohen, Robert M
|
|
|
2 |
4 |
p. 264-265
|
article
|
| 2 |
Avi Friedman: designs on a healthy future
|
Pirisi, Angela
|
|
|
2 |
4 |
p. 278
|
article
|
| 3 |
Childhood and adolescent overweight and obesity in Latin America: a systematic review
|
Rivera, Juan Ángel
|
|
|
2 |
4 |
p. 321-332
|
article
|
| 4 |
Correction to Lancet Diabetes Endocrinol 2014; 2: 19–29
|
|
|
|
2 |
4 |
p. e11
|
article
|
| 5 |
Correction to Lancet Diabetes Endocrinol 2013; published online July 30
|
|
|
|
2 |
4 |
p. e11
|
article
|
| 6 |
Diabetes: a challenge for China in the 21st century
|
Jia, Weiping
|
|
|
2 |
4 |
p. e6-e7
|
article
|
| 7 |
Follicular thyroid carcinoma presenting as a soft tissue thigh mass
|
Olejarski, Jamie
|
|
|
2 |
4 |
p. 348
|
article
|
| 8 |
Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study
|
Selvin, Elizabeth
|
|
|
2 |
4 |
p. 279-288
|
article
|
| 9 |
GLP-1 receptor agonists: why is once weekly inferior to once daily?
|
Garber, Alan J
|
|
|
2 |
4 |
p. 266-267
|
article
|
| 10 |
Obesity prevention in Latin America: now is the time
|
The Lancet Diabetes & Endocrinology,
|
|
|
2 |
4 |
p. 263
|
article
|
| 11 |
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
|
Pratley, Richard E
|
|
|
2 |
4 |
p. 289-297
|
article
|
| 12 |
Research in brief
|
Kang, Seema
|
|
|
2 |
4 |
p. 277
|
article
|
| 13 |
Stress hyperlactataemia: present understanding and controversy
|
Garcia-Alvarez, Mercedes
|
|
|
2 |
4 |
p. 339-347
|
article
|
| 14 |
TANDEM: understanding diabetes and tuberculosis
|
van Crevel, Reinout
|
|
|
2 |
4 |
p. 270-272
|
article
|
| 15 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis
|
Bolland, Mark J
|
|
|
2 |
4 |
p. 307-320
|
article
|
| 16 |
The puzzling world of vitamin D insufficiency
|
Michaëlsson, Karl
|
|
|
2 |
4 |
p. 269-270
|
article
|
| 17 |
Turner's syndrome: challenges of late diagnosis
|
Lee, Marilyn Cheng
|
|
|
2 |
4 |
p. 333-338
|
article
|
| 18 |
Vitamin D and prevention of diabetes: is lifelong endogenous vitamin D needed?
|
Pilz, Stefan
|
|
|
2 |
4 |
p. 267-268
|
article
|
| 19 |
Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study
|
Afzal, Shoaib
|
|
|
2 |
4 |
p. 298-306
|
article
|
| 20 |
Vitamin D status and ill health
|
Naughton, Declan
|
|
|
2 |
4 |
p. 274-275
|
article
|
| 21 |
Vitamin D status and ill health
|
Feelisch, Martin
|
|
|
2 |
4 |
p. e8
|
article
|
| 22 |
Vitamin D status and ill health
|
Macdonald, Helen M
|
|
|
2 |
4 |
p. e8-e9
|
article
|
| 23 |
Vitamin D status and ill health
|
Giovannucci, Edward
|
|
|
2 |
4 |
p. 273
|
article
|
| 24 |
Vitamin D status and ill health
|
Garland, Cedric F
|
|
|
2 |
4 |
p. e10
|
article
|
| 25 |
Vitamin D status and ill health
|
Holick, Michael F
|
|
|
2 |
4 |
p. 273-274
|
article
|
| 26 |
Vitamin D status and ill health
|
de Tena, Jaime García
|
|
|
2 |
4 |
p. e9-e10
|
article
|
| 27 |
Vitamin D status and ill health
|
Harvey, Nicholas C
|
|
|
2 |
4 |
p. e9
|
article
|
| 28 |
Vitamin D status and ill health – Author's reply
|
Autier, Philippe
|
|
|
2 |
4 |
p. 275-276
|
article
|
Journal description